The present study proposes a validated dissolution method for empagliflozin (EMPA) in film coated tablets. A gradual in vitro dissolution profile for this formulation was obtained using 900 mL of hydrochloric acid 0.01 M at 37 °C ± 0.5 °C as dissolution medium and USP apparatus 2 (paddle) at 50 rpm. The dissolved percentage of EMPA was quantified by ultraviolet spectrophotometric method to obtain cost technique and produce little residual solvents. Validation parameter for dissolution methodology such as the specificity, linearity, accuracy and precision were evaluated according to the international guidelines, giving results within the acceptable range. The method is linear in the range of 1 - 40 µg/mL, precise, with RSD value less than 2....
The first method by micellar electrokinetic chromatography (MEKC) for the determination of empaglifl...
A novel dissolution method was developed, suitable for powder mixtures, based on the USP basket appa...
Purpose: To develop and validate a dissolution test method for tablets containing 80 mg of drotaveri...
The present study proposes a validated dissolution method for empagliflozin (EMPA) in film coated ta...
The present study proposes a validated dissolution method for empagliflozin (EMPA) in film coated ta...
The aim of this study was to develop and validate a dissolution test for the quality control of defl...
The aim of this study was to develop and validate a dissolution test for favipiravir release in a ta...
Background: Reversed-phase HPLC (RP-HPLC) is a prevalent chromatographic technique in the pharmaceut...
Abstract Background A stability-indicating RP-HPLC method was developed and validated for the estima...
Objective: The present study aims at developing an accurate precise, rapid and sensitive Reverse Pha...
Objective: The present study aims at developing an accurate precise, rapid and sensitive Reverse Pha...
The development of a meaningful dissolution procedure for drug products with limited water solubilit...
Fixed dose tablets are gaining value as they give a Fixed dose combination therapy (FDC) method for ...
Objective: Linagliptin is used to treat type-2 diabetes. It is available singly as 5 mg tablet. Sinc...
Purpose: To develop and validate a dissolution test method for tablets containing 80 mg of drotaveri...
The first method by micellar electrokinetic chromatography (MEKC) for the determination of empaglifl...
A novel dissolution method was developed, suitable for powder mixtures, based on the USP basket appa...
Purpose: To develop and validate a dissolution test method for tablets containing 80 mg of drotaveri...
The present study proposes a validated dissolution method for empagliflozin (EMPA) in film coated ta...
The present study proposes a validated dissolution method for empagliflozin (EMPA) in film coated ta...
The aim of this study was to develop and validate a dissolution test for the quality control of defl...
The aim of this study was to develop and validate a dissolution test for favipiravir release in a ta...
Background: Reversed-phase HPLC (RP-HPLC) is a prevalent chromatographic technique in the pharmaceut...
Abstract Background A stability-indicating RP-HPLC method was developed and validated for the estima...
Objective: The present study aims at developing an accurate precise, rapid and sensitive Reverse Pha...
Objective: The present study aims at developing an accurate precise, rapid and sensitive Reverse Pha...
The development of a meaningful dissolution procedure for drug products with limited water solubilit...
Fixed dose tablets are gaining value as they give a Fixed dose combination therapy (FDC) method for ...
Objective: Linagliptin is used to treat type-2 diabetes. It is available singly as 5 mg tablet. Sinc...
Purpose: To develop and validate a dissolution test method for tablets containing 80 mg of drotaveri...
The first method by micellar electrokinetic chromatography (MEKC) for the determination of empaglifl...
A novel dissolution method was developed, suitable for powder mixtures, based on the USP basket appa...
Purpose: To develop and validate a dissolution test method for tablets containing 80 mg of drotaveri...